Otorhinolaryngologic Diseases
30
1
3
18
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.7%
2 terminated out of 30 trials
90.0%
+3.5% vs benchmark
3%
1 trials in Phase 3/4
22%
4 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (30)
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma
Reconstruction Implant Bone After Removal Using Porous Titanium Prosthesis
Implantation of the HiRes90K™ Advantage Cochlear Implant With HiFocus™ Mid-Scala and Development of a Combined Electric and Acoustic Stimulation Technology in Adults With Partial Deafness
Effects of an Online Hearing Support for First-time Hearing Aid Users
A Phase I/II Clinical Trial with SENS-501 in Children Suffering from Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations
BiZact Tonsillectomy in the Pediatric Population
Study on the Efficacy and Safety of a Device for Post-op Recovery in Pediatric Adenectomy/Adenotonsillectomy.
Impact of Spa Treatments on the Consumption of Care in Children
Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss
A Predictive Model for Oropharyngeal Dysphagia in Non-hospitalized Older Patients
Evaluation of Potential Causes of Nap Modulated Tinnitus
Antibiotic Education for Children in an Emergency Care Unit
Clinical Evaluation of a Cochlear Implant Sound Processor
Investigation of an Updated Bone-anchored Sound Processor
Home-based Transcranial Electrical Stimulation (TES) in Patients With Chronic Tinnitus
Tonsillectomy Using BiZact™ - a Randomized Side-controlled Clinical Trial
Psychiatric Comorbidity
Type and Frequency of Nasal Irrigation in Rhinosinusitis Patients
Tinnitus in Patients With and Without Sensorineural Hearing Loss
Tap to "Tap", Pathobiome Associates Health Care